322 research outputs found

    Article 6: Bulk Transfers

    Get PDF

    Article 2: Sales

    Get PDF

    Article 3: Commercial Paper

    Get PDF

    Article 10: Effective Date and Repealer

    Get PDF

    Constraints on spin observables in antiproton-proton to antiLambda-Lambda

    Full text link
    It is recalled that spin-observables in the strangeness-exchange reaction pˉp→ΛˉΛ\bar{p}{p} \to \bar{\Lambda}{\Lambda} are not independent but are related to each other by simple algebraic relations. This provides constraints on the existing data on polarization and spin-correlation coefficients, and also on the forthcoming data obtained using a polarized proton target.Comment: RevTex, 9 page

    Status of Coral Reefs in the US Caribbean and Gulf of Mexico: Florida, Texas, Puerto Rico, US Virgin Islands and Navassa

    Get PDF
    The following report on the status of US Caribbean coral reef ecosystems has been summarised from more extensive reports submitted to the US Coral Reef Task Force (USCRTF) working group that implemented in 2000 ‘A National Program to Assess, Inventory, and Monitor US Coral Reef Ecosystems’. The more-lengthy reports are also the basis for the biennial-issued document, ‘Status and Trends of US Coral Reef Ecosystems’. Each author is a recognised technical expert with responsibility for monitoring and/or managing aspects of their respective coral reef ecosystems

    Suppression of HBV by Tenofovir in HBV/HIV coinfected patients : a systematic review and meta-analysis

    Get PDF
    Background: Hepatitis B coinfection is common in HIV-positive individuals and as antiretroviral therapy has made death due to AIDS less common, hepatitis has become increasingly important. Several drugs are available to treat hepatitis B. The most potent and the one with the lowest risk of resistance appears to be tenofovir (TDF). However there are several questions that remain unanswered regarding the use of TDF, including the proportion of patients that achieves suppression of HBV viral load and over what time, whether suppression is durable and whether prior treatment with other HBV-active drugs such as lamivudine, compromises the efficacy of TDF due to possible selection of resistant HBV strains. Methods: A systematic review and meta-analysis following PRISMA guidelines and using multilevel mixed effects logistic regression, stratified by prior and/or concomitant use of lamivudine and/or emtricitabine. Results: Data was available from 23 studies including 550 HBV/HIV coinfected patients treated with TDF. Follow up was for up to seven years but to ensure sufficient power the data analyses were limited to three years. The overall proportion achieving suppression of HBV replication was 57.4%, 79.0% and 85.6% at one, two and three years, respectively. No effect of prior or concomitant 3TC/FTC was shown. Virological rebound on TDF treatment was rare. Interpretation: TDF suppresses HBV to undetectable levels in the majority of HBV/HIV coinfected patients with the proportion fully suppressed continuing to increase during continuous treatment. Prior treatment with 3TC/FTC does not compromise efficacy of TDF treatment. The use of combination treatment with 3TC/FTC offers no significant benefit over TDF alone

    Brief of Amici Curiae Scholars of the Law of Non-Profit Organizations in Support of Respondent: Americans for Prosperity Foundation v. Matthew Rodriguez, Nos. 19-251 & 19-255

    Get PDF
    This was a brief filed with the Supreme Court of the United States supporting the state of California in its effort to defend the Constitutionality of a law regarding nonprofit organizations requiring that those organizations soliciting donations in the state of California file a Schedule B of the Form 990 with the state attorney general to disclose substantial donors to the organization during the year
    • …
    corecore